3Maertens J, Erhaegen J, Lagrou K, et al. Screening for circalating galaetoniannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation [ J ]. Blood,2001 ; 97 : 1604-1610.
3Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation[J]. Am J Respir Crit Care Med,2004,170: 22-48.
4Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[J]. N Engl J Med,2002,347: 408-415.
6Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus[J]. Clin Infect Dis,2002,34: 7-14.
7Bretagne S, Marmorat-Khuong A, M Kuentz, et al. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients[J]. J Infect, 1997,35: 7-15.
8Walsh TJ, Shoham S, Petraitiene R, et al. Detection of galactomannan antigenemia in patients receiving piperacillintazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction[J]. J Clin Microbiol,2004,42 : 4744-4748.
9Gangneux JP, Lavarde D, Bretagne S, et al. Transient Aspergillus antigenemia: think of milk[J]. Lancet, 2002,359 : 1251.
10Maertens J, Verhaegen J, Lagrou K, et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation[J].Blood,2001,97: 1604-1610.
